MeSH term
Frequency | Condition_Probility | Female | 23 | 0.0 |
Humans | 43 | 0.0 |
Mutation | 6 | 0.0 |
Animals | 11 | 0.0 |
Ion Channels/*genetics/metabolism | 2 | 25.0 |
Neurons/*metabolism | 5 | 1.0 |
Research Support, Non-U.S. Gov't | 31 | 0.0 |
Amino Acid Sequence | 6 | 0.0 |
Base Sequence | 11 | 0.0 |
DNA/genetics | 2 | 0.0 |
DNA Primers | 3 | 0.0 |
Exons | 3 | 0.0 |
*Introns | 3 | 1.0 |
Molecular Sequence Data | 10 | 0.0 |
Polymerase Chain Reaction | 10 | 0.0 |
*Polymorphism, Genetic | 6 | 0.0 |
Receptors, Nicotinic/*genetics | 22 | 36.0 |
Mutation/*genetics | 3 | 0.0 |
Receptors, Nicotinic/*genetics/metabolism | 2 | 50.0 |
Amino Acid Substitution | 2 | 0.0 |
Male | 24 | 0.0 |
Mice | 5 | 0.0 |
Mice, Inbred Strains | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 5 | 0.0 |
Adolescent | 5 | 0.0 |
Alleles | 7 | 0.0 |
Attention Deficit Disorder with Hyperactivity/*genetics | 2 | 4.0 |
Child | 4 | 0.0 |
Child, Preschool | 3 | 0.0 |
Gene Frequency | 3 | 0.0 |
Genotype | 6 | 0.0 |
Protein Subunits | 2 | 0.0 |
Anticonvulsants/therapeutic use | 2 | 8.0 |
Diagnosis, Differential | 2 | 0.0 |
*Genes, Dominant | 6 | 2.0 |
Models, Neurological | 2 | 1.0 |
Receptors, Nicotinic/genetics | 3 | 23.0 |
Adult | 10 | 0.0 |
English Abstract | 2 | 0.0 |
Potassium Channels, Voltage-Gated | 2 | 3.0 |
Syndrome | 3 | 0.0 |
Epilepsy, Generalized/*genetics | 2 | 7.0 |
Polymorphism, Genetic | 5 | 0.0 |
Chromosome Mapping | 8 | 0.0 |
Epilepsy, Frontal Lobe/*genetics | 8 | 80.0 |
Pedigree | 14 | 0.0 |
Family | 3 | 0.0 |
Genetic Markers | 3 | 0.0 |
Haplotypes | 3 | 0.0 |
Polymorphism, Genetic/*genetics | 3 | 0.0 |
Comparative Study | 6 | 0.0 |
Exons/genetics | 3 | 0.0 |
Genes, Dominant | 4 | 0.0 |
*Mutation, Missense | 2 | 0.0 |
Phenotype | 4 | 0.0 |
DNA Mutational Analysis | 6 | 0.0 |
Aged | 2 | 0.0 |
Middle Aged | 4 | 0.0 |
*Mutation | 3 | 0.0 |
*Circadian Rhythm | 3 | 1.0 |
Electroencephalography | 3 | 1.0 |
Hippocampus/metabolism | 2 | 2.0 |
Rats | 3 | 0.0 |
Polymorphism, Single-Stranded Conformational | 3 | 0.0 |
Epilepsy/*genetics | 3 | 9.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Introns | 2 | 0.0 |
Linkage (Genetics) | 3 | 0.0 |
Receptors, Nicotinic/chemistry/*genetics | 2 | 66.0 |
DNA, Complementary | 2 | 0.0 |
Heterozygote | 2 | 0.0 |
*Chromosomes, Human, Pair 20 | 4 | 3.0 |
Infant | 2 | 0.0 |
Heterozygote Detection | 2 | 0.0 |
